Clinical Trial: AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp Study
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Diabetes Mellitus, Type 2
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Single Centre, Single Dose, Randomised, Double-blind, Two-way Crossover, Glucose Clamp Study Investigating the Pharmacodynamics, Pharmacokinetics, and Safety of Ultra-rapid-acting Concentra
Brief Summary:
This is a phase 1, single dose, randomised, double-blind, two-way crossover study to compare ultra-rapid-acting concentrated insulin aspart AT278 (U500/mL) with standard insulin aspart NovoRapid® (U100/mL) in participants with T2D.Participants and Investigators will be blinded to both study interventions.Humulin® R U-500 (U500/mL), a highly concentrated regular human insulin, will be used as an open-label comparator.
Read more